10,11
Furthermore, silver nanoparticles have been found to display size-dependent toxicity when exposed to alveolar macrophages via induction of oxidative stress, 12, 13 while quantum dots and fullerenes can also initiate an inflammatory response and generation of reactive oxygen species.
14Ϫ16
Cerium oxide nanoparticle (nanoceria) is a unique nanomaterial because it exhibits anti-inflammatory properties. Nanoceria has been found to scavenge reactive oxygen species (ROS), possess superoxide-dismutaselike activity, prevent cardiovascular myopathy, and provide radioprotection to normal cells from radiation. 17Ϫ21 We recently reported the synthesis of biocompatible polymer-coated nanoceria with enhanced aqueous stability and unique pH-dependent antioxidant activity. 17 In particular, we have found that nanoceria displays optimal antioxidant properties at physiological pH, whereas it behaves as an oxidase at acidic pH. 22 Hence, this selective behavior may explain nanoceria's selective cytoprotection to normal cells but not to cancer cells during radiation treatment or oxidative stress. 20 In addition, the nature of the polymeric coating surrounding the cerium oxide core could play a critical role in nanoceria's beneficial (antioxidant) vs harmful (oxidant) properties. We also reasoned that the cytotoxicity of cerium oxide nanoparticles could depend upon their *Address correspondence to jmperez@mail.ucf.edu subcellular localization. Once inside the cells, the nanoparticle's toxicity could depend on whether they are localized in particular cellular organelles, such as the lysosomes (which are acidic), or distributed in the cytoplasm (which is at neutral pH in normal cells). In addition, since most tumors have an acidic microenvironment, this might switch off nanoceria's antioxidant activity, turning on its oxidase activity and consequently sensitizing the tumor toward radiation therapy.
In this work, we report the polymer's surface-chargedependent cell internalization and cytotoxicity profile of cerium oxide nanoparticles in normal vs malignant cells. We selected various cell lines in order to assess the corresponding behavior of cerium oxide nanoparticles. Cardiac myocytes (H9c2) and human embryonic kidney (HEK293) cells were selected as nontransformed (normal) cells, whereas lung (A549) and breast (MCF-7) carcinomas were selected as transformed (cancer) cell lines. Results showed that positively charged nanoceria internalized in all cells except for the breast carcinoma, localizing preferentially in the lysosomes and subsequently becoming toxic to these cells. In contrast, nanoceria with a negative charge was internalized only by lung carcinoma (A549) cells but not by the breast carcinoma cells (MCF-7), thus exhibiting toxicity only to the lung carcinoma cells. Notably, the negative charged nanoceria localized into the lysosomes of the A549 cells, while they were not internalized and therefore were not toxic to the normal cells (either cardiac myocytes or human embryonic kidney cells). Surprisingly, nanoceria with neutral charge was not toxic to normal cells or cancer cells, as these nanoparticles primarily localized in the cytoplasm of these cells. Taken together, our results suggest that the internalization and subcellular localization of polymer-coated nanoceria plays a critical role in the toxicity profile of this nanomaterial. Our results also suggest that the coating on nanoceria can be engineered in order to modulate its differential cytotoxicity behavior in cancer vs normal cells.
RESULTS
Synthesis and Characterization of Polymer-Coated Cerium Oxide Nanoparticles. For our studies, we synthesized various nanoceria preparations coated with either poly-(acrylic acid) (PNC), aminated poly(acrylic acid) (ANC), or dextran (DNC) (Scheme 1), endowing our nanoparticles with a negative (Ϫ), positive (ϩ), or neutral (0) surface charge, respectively. Transmission electron microscopy (TEM) studies showed the presence of nanoparticles of similar core size (3Ϫ4 nm) in all preparations as reported previously 22 ( Figure 1a ). Dynamic light-scattering experiments showed the presence of monodisperse nanoceria preparations with an average hydrodynamic diameter of 14 nm for DNC(0) and 5 nm for both PNC(ϩ) and ANC(Ϫ) (see the Supporting Information, Figure S1 ). The presence of different surface charges in the various nanoceria preparations was assessed by potential (Figure 1b) , confirming the presence of a negative, neutral, and positive charge for PNC, DNC, and ANC, respectively. FT-IR analysis further confirmed the nanoparticle's polymer surface coating and functionality (Figure 1c ). During synthesis, we fluores- www.acsnano.org cently labeled the nanoparticles by encapsulating a dye (DiI) within the hydrophobic microdomains of the polymeric coatings of each nanoceria preparation, following a previously reported methodology. 23 Therefore, using this approach, we introduced fluorescent modality to the polymer-coated nanoceria, without compromising the solubility of the nanoparticles in aqueous media or reducing the number of available functional groups on the nanoparticle surface. Successful encapsulation of DiI into the nanoceria was confirmed via fluorescence spectroscopy, where a blue shift in the DiIencapsulating ceria nanoparticles (584 nm) emission spectrum was observed as opposed to DiI alone (592 nm) (Figure 1d ). The DiI-encapsulating polymer-coatednanoceria displayed good aqueous stability over long periods of time without significant release of the dye and can be used for the intracellular tracking of the nanoparticles.
Nanoceria's Surface-Charge-Dependent Cellular Interaction. Confocal microscopy experiments were performed in order to study the cellular uptake and intracellular localizaton of the DiI-labeled polymer-coated nanoceria. In these experiments, PNC(Ϫ), ANC(ϩ), and DNC(0) (1.0 mM) were incubated with two transformed carcinoma cell lines (A549 lung and MCF-7 breast carcinomas) and two nontransformed (normal) cell lines (H9c2 cardiac myocytes and HEK293 human embryonic kidney cells). We selected these cell lines in order to investigate if they differently uptake the ANC(ϩ), PNC(Ϫ), and DNC(0) nanoparticles, thus potentially displaying different toxicity profiles.
First, we studied the internalization pattern of ANC(ϩ), PNC(Ϫ), and DNC(0) in the two normal cells [HEK293 and H9c2 (10000 cells)] (Figure 2 ). After a 3 h incubation, results showed that the negatively charged carboxylated nanoparticles [PNC(Ϫ)] were minimally uptaken by the HEK293 cells and did not internalize in the H9c2 cell line. Meanwhile, the positively charged aminated nanoparticles [ANC(ϩ)] were uptaken by both cells, with the H9c2 cardiac myocytes uptaking more nanoparticles than the HEK293 human embryonic kidney cells, as indicated by the elevated cellassociated fluorescence in the H9c2 cells. The neutral dextran-coated nanoparticle [DNC(0)] was internalized by both cell lines, although a higher degree of internalization was observed in the H9c2 as opposed to the HEK293. Interestingly, the DNC(0) intracellular fluorescence pattern (particularly in the H9c2 cells) was diffused, being different from the ANC(ϩ)-punctuated fluorescence pattern. This difference seems to indicate a unique nanoparticle surface-charge dependent internalization mechanism with different intracellular compartmentalization among the nanoparticles studied and these two nontransformed cell lines.
Internalization experiments preform with cancer cells (10000 cells) derived from lung (A549) and breast (MCF-7) carcinomas revealed PNC(Ϫ) uptake by the A549 cells but no uptake by the MCF-7 cells (Figure 3 ). In contrast, both cell lines were able to uptake ANC(ϩ). Interestingly, a higher degree of internalization and pronounced punctuated fluorescence was observed with the ANC(ϩ) in the A549 cells. This might indicate that in these cells the majority of the ANC(ϩ) localized into endosomal compartments. In contrast, minimal and diffused intracellular fluorescence was observed with the DNC(0) in both the A549 and MCF-7 cells, suggesting that these nanoparticles are mostly localized in the cytosol with a small fraction confined within the endosomal compartments. Taken together, the above results suggest that the surface charge on polymer-coated nanoceria dictates their differential internalization and localization in normal vs cancer cells ( Figures 2 and 3 , respectively). Cellular Mechanism of Nanoparticle Uptake. To further investigate the mechanism of cellular uptake and verify if the endocytic pathway is responsible for the internalization of polymer-coated nanoceria, we performed a series of experiments at 4°C and with endocytic inhibitors [2-deoxyglucose (50 mM) and sodium azide (10 mM)]. For instance, at 4°C the endocytic/pinocytic mechanism is arrested.
24Ϫ26 Thus, after incubating cells (10000 cells) with the various DiI-labeled nanoceria preparations (1.0 mM) at 4°C, we observed negligible nanoparticle internalization ( Figure 4aϪc ). Since none of the polymer-coated nanoceria entered the A549 lung carcinoma or H9c2 cardiac myocytes cells, it was suggested that endocytosis is a possible mechanism of internalization in all cases. Experiments performed at 37°C in the presence of 2-deoxyglucose and sodium azide confirmed our results ( Figure 4dϪf ). Specifically, both A549 and H9c2 cells did not uptake the DiI-labeled nanoceria [PNC(Ϫ), ANC(ϩ), or DNC(0)] in the presence of these inhibitors as expected. These results confirm that these nanoparticles were actively uptaken by an endocytic process. Since PNC(Ϫ) were not significantly uptaken by the H9c2 cells, experiments using these cells at 4°C or in the presence of inhibitors were not performed.
Intracellular Distribution of Polymeric Cerium Oxide Nanoparticles. To corroborate that after internalization some of the polymer-coated nanoceria localized in endosomal compartments, we first treated the cells Meanwhile, when the DiI-labeled-DNC(0) was used, a diffused distribution of internalized nanoparticles (DiI signal) was observed with minimal colocalization with the lysosomes (Figure 6dϪf and Figure S3 , Supporting Information). This indicates that in H9c2 cardiac myocytes, the neutral DiI-labeled-DNC(0) primarily localizes to the cytosol while the DiI-labeled-ANC(ϩ) localized to the lysosome. Lysosomal colocalization experiments were not done using H9c2 and DiI-labeled PNC(Ϫ) since these nanoparticles are not uptaken by these cells (Figure 2 ). These results demonstrate that the surface charge on the ceria nanoparticles dictates the nanoparticles' subcellular localization in cancer and normal cells.
Determination of the Oxidase-Like Activity of Lysosome-Residing Nanoceria. Nanoceria has been reported to possess unique oxidase-like activity at acidic pH, oxidizing various colorimetric substrates, such as 3,3=,5,5=-tetramethylbenzydine (TMB) and 2,2-azinobis(3-ethylbenzothizoline-6-sulfonic acid (AzBTS). 22 This activity can be employed to assess the localization of nanoceria in various cell organelles, particularly lysosomes, via the nanoparticle's oxidase activity, using TMB as the colorimetric substrate. Hence, to further confirm that some of the polymer-coated cerium oxide nanoparticles localized into the lysosomes, cells were incubated with the different nanoceria preparations for 3 h, followed by lysosomal isolation. Then, the oxidase activity of the isolated lysosomes was determined spectrophotometrically via TMB oxidation. As expected and in agreement with the microscopy and lysosomal colocalization experiments, we found that ANC(ϩ) were mostly entrapped within the lysosome of the H9c2, HEK293, and A549 cell lines, as the lysosomes isolated from these cells exhibited significant levels of oxidase activity (Figure 7aϪc) . In MCF-7 breast carcinoma cell line, no localization to the lysosomes was observed as these cells do not uptake any of the nanoparticles (Figure 7d ). Interestingly, when cells were incubated with PNC(Ϫ), only the lysosomes isolated from A549 lung carcinoma cells exhibited oxidase activity as expected on the basis of the lysosomal colocalization experiments. Meanwhile, the lysosomes from cells incubated with the DNC(0) exhibit minimal oxidase activity, corroborating the confocal microscopy studies. Lysosomes isolated from untreated cells (H9c2, HEK293, A549, and MCF-7) did not possess any oxidase activity (control), as indicated by the absence of TMB oxidation ( Figure 7 ) and confirming the absence of endogenous oxidase activity in these organelles. Intracellular-Distribution-Dependent Cytotoxicity of Polymeric Cerium Oxide Nanoparticles. In order to determine if the surface-charge-dependent internalization and intracellular (lysosomal vs cytoplasmic) localization of the polymeric nanoceria plays a role in the nanoparticle's cytotoxicity, cell viability (MTT) assays were performed. Interestingly, we found that DNC(0) did not exhibit any toxicity to the cell lines studied (Figure 8 ), as most of these nanoparticles localized to the cytoplasm. Furthermore, prolonged incubation of these cell lines with the dextran-coated-nanoceria did not affect cell morphology and proliferation ability as previously reported. 17 In contrast, ANC(ϩ) and PNC(Ϫ) had different degrees of toxicity, depending on the nanoparticle's localization inside the cell. For instance, the PNC(Ϫ) nanoparticles were not toxic to the H9c2 cardiac myocytes or the HEK293 kidney cells (Figure 8a,b) , whereas they were toxic to the A549 lung carcinoma cells (Figure 8c ). This can be explained by the minimal uptake of PNC(Ϫ) by normal cells, as opposed to the A549 cancer cells that exhibited enhanced nanoparticle uptake and localization to the lysosomes (Figure 5dϪf and Figure 7c ). ANC(ϩ) also exhibited various degrees of toxicity. Notably, these nanoparticles were more toxic to H9c2, A549, and HEK 293 cells, since these cells exhibited increased nanoparticle internalization and lysosomal localization. Interesitingly, the breast cancer cells (MCF-7) did not show any toxicity after treatment with any of the nanoparticles studied, since these cells did not show any significant nanoparticle uptake. Incubation of the H9c2 and A549 cells with ANC(ϩ) in the presence of inhibitors of endocytic pathway (2-deoxyglucose and sodium azide) abrogated the nanoparticle's cytotoxicity (Figure 9a,b) , confirming that an endocytic uptake of these nanoparticles and eventual localization to lysosomes was responsible for their cellular toxicity. Taken together, these results demonstrate that localization of nanoceria into lysosomes (an acidic cell compartment), as opposed to localization into the cytoplasm, leads to cytotoxicity by activating the oxidase activity of nanoceria within these organelles.
Comparison of the Toxicity of Surface-Charge-Engineered Nanoceria and Iron
Oxide Nanoparticles. To demonstrate that the observed cytotoxicity of nanoceria is attributed to the cerium oxide core (oxidase activity) and not to the nature of the polymeric coating, we performed experiments with DiI-labeled-aminated poly(acrylic acid) [IONP(ϩ)] and DiI-labeled carboxylated poly(acrylic acid) [IONP(Ϫ)] coated iron oxide nanoparticles. Polymer-coated iron oxide nanoparticles have been widely used in various applications, particularly in magnetic resonance imaging (MRI) with minimal toxicity. For instance, various preparations of dextran-coated iron oxide nanoparticles are used in the clinic for liver and lymph node metastasis imaging.
27Ϫ29 Confocal microscopy studies of A549 and H9c2 cells incubated with these nanoparticles showed that IONP(ϩ) were uptaken by the A549 lung carcinoma cells and H9c2 cardiac myocytes (Figure 10a,c) , with a more punctuated internalization in the H9c2 cells, indicating lysosomal localization. In contrast, IONP(Ϫ) were not internalized by both cells (Figure 10b,d ). As expected, the polymeric iron oxide nanoparticles [IONP(ϩ) and IONP(Ϫ)] were not toxic to either the nontransformed H9c2 cell line or the transformed A549 carcinoma cell line ( Figure  11a,b) . The fact that more of the IONP(ϩ) nanoparticles were localized into the lysosomes upon internalization in H9c2 did not seem to significantly alter the toxicity profile of the polymer-coated iron oxide nanoparticles. These results are not surprising, as iron oxide nanoparticles do not possess oxidase activity, particularly at the low pH of the lysosomes. Therefore, we can conclude that the intrinsic oxidase behavior of cerium oxide nanoparticles is responsible for the nanoparticle's cytotoxicity, particularly when they localize into acidic cell compartments such as lysosomes. Cytotoxicity experiments with the neutral dextran-coated iron oxide nanoparticles were not performed since it is well established that these nanoparticles are nontoxic.
27Ϫ29

DISCUSSION
The toxicity of nanomaterials depends on various factors, including the nature and chemical composi- tion of the nanoparticle's core, mode of synthesis, size, shape, and crystallinity, surface reactivity, solubility in aqueous media, and degree of aggregation. 8, 24 Although efforts have been made to study the effect of the polymeric surface coating and surface charge on the uptake, localization, and toxicity of nanomaterials, the mechanistic implications are still not completely understood. This is highly important as some nanomaterials, such as cerium oxide, may display either a beneficial (antioxidant) or toxic (oxidant) effect, depending on the pH of the compartment where they localize inside the cell. Here, we have shown that polymer-coated nanoceria displays different levels of toxicity, depending upon cellular uptake and subsequent subcellular localization. We have found that when polymer-coated nanoceria internalize and localize in the lysosomes, they become toxic due to the acidic microenvironment of these organelles, which activates the oxidase activity of nanoceria (Scheme 2). However, lower toxicity is observed when polymer-coated nanoceria localize into the cytoplasm of cells and are not internalized by the cells. Our results also show that the internalization, eventual localization, and cytotoxicity of polymercoated nanoceria within the cell greatly depend on the surface charge of the polymeric coating and the type of cell (cancerous vs normal). For instance, we have found that the aminated nanoceria [ANC(ϩ)] were toxic to most of the cancer and normal cell lines studied, as these nanoparticles were uptaken and localized mostly into the lysosomes. This might indicate that nanoceria's intrinsic oxidant behavior at acidic pH is responsible for the observed cytotoxic of the cationic polymer-coated nanoparticles [ANC(ϩ)]. Meanwhile, PNC(Ϫ) internalized mostly into the A549 lung carcinoma cells but not significantly into any of the other cell lines studied. This observation is corroborated by the fact that no lysosomal localization and therefore no toxicity is observed in MCF-7, H9c2 or HEK293 cells treated with PNC(Ϫ). In contrast, significant lysosomal localization and cytotoxicity is observed in the A549 cells treated with PNC(Ϫ). Surprisingly, distinct changes in cellular uptake were observed with the dextrancoated cerium oxide nanoparticles [DNC(0)]. A very disperse and diffused intracellular distribution was seen in all cell lines (cancer and normal) exposed to DNC(0), with very few of the DNC(0) localizing into the lysosomes. Therefore, the neutral DNC(0) nanoparticles were found to be nontoxic to any of the cell lines studied as they localize primarily in the cytoplasm. This suggests that the observed nontoxic behavior of DNC(0) might be attributed to its significantly low entrapment into lysosomes, contrary to ANC(ϩ). On the basis of these results, DNC(0) would be a great platform for further development of therapeutic antioxidant nanoagents, as they exhibit minimal toxicity. In addtion, they can be effectively used in radiation therapy, since they are not toxic to normal cells. Also, as other dextran-coated nanoparticles have been found to have long circulation time, 27Ϫ29 similarly dextran-coated cerium oxide nanoparticles can be employed as long circulating antioxidant nanoagents.
Another factor that may contribute to the cytotoxic behavior of polymer-coated nanoceria is the type of cell line used and pH of the cell's microenvironment.
30Ϫ33 This is particularly relevant as tumor progression, increased invasion, metastasis, and acidic tumor environment have been found to be interrelated. 34Ϫ36 Differences between normal and tumor tissue and tumor-to-tumor variation may play a key www.acsnano.org role in dictating the antioxidant vs oxidase behavior of the polymer-coated nanoceria. Previously, we have reported that polymer-coated nanoceria displays unique oxidase-like behavior at slightly acidic pH. 22 Therefore, in view of this oxidase-like property at acidic pH, intracellular distribution of the polymer-coated nanoceria into the lung carcinoma's lysosomes may be the reason for these nanoparticles' cytotoxicity. In addition, as A549 lung carcinoma cells and most tumors have been found to have upregulated glycolysis and increased lactic acid production, 30Ϫ33 this effect might further contribute toward the buildup of an acidic microenvironment, favoring nanoceria's oxidase activity and therefore sensitizing tumors toward radiation therapy. In summary, we believe that understanding the role of the polymer-coated nanoceria's surface charge and the influence that it has in the cell internalization, subcellular distribution, and differential antioxidant/oxidant activity will shed new light in delineating the mechanisms that lead to nanoceria's toxicity.
MATERIALS AND METHODS
Synthesis of Polymer-Coated Nanoceria Preparations [DNC(0), PNC(؊), and ANC(؉)].
The polymer-coated nanoceria preparations DNC(0) and PNC(Ϫ) were synthesized using the methodology described previously. 22 Briefly, a solution of cerium(III) nitrate (2.17 g, 1.0 M, Aldrich, 99%) in water (5.0 mL) was mixed separately with an aqueous solution of either poly(acrylic acid) (PAA, 0.5 M, Sigma) or dextran (1.0 M, Sigma) and mixed thoroughly using a vortex mixer. The resulting mixture was then added to an ammonium hydroxide solution (30.0 mL, 30%, Sigma Aldrich) under continuous stirring for 24 h at room temperature. The preparation was then centrifuged at 4000 rpm for two 30 min cycles to settle any debris and large agglomerates. The supernatant solution was then purified from free polymers and other reagents and then concentrated using a 30K Amicon cell (Millipore Inc.). ANC(ϩ) was synthesized directly from PNC(Ϫ). In this method, PNC(Ϫ) (5.0 mL, 1.5 mg/mL) was treated with EDC [1-ethyl-3- an additional 3 h at room temperature. The resulting solution was purified to remove excess EDA and other reagents using an Amicon dialysis membrane (MWCO 30K) from Millipore. The final ANC(ϩ) preparation (1.5 mg/mL) in DI water was stored in the refrigerator for further characterization. DiI Encapsulation in Polymer-Coated Nanoceria [DNC(0), PNC(؊), and ANC(؉)]. In order to encapsulate the DiI dye (Invitrogen) into the polymeric matrix of the various polymer-coated nanoceria, we have used a modified solvent diffusion method, as reported previously. 23 Briefly, to 4.0 mL of the nanoparticle solution [1.5 mg/ mL, DNC(0), PNC(Ϫ), or ANC(ϩ)], was added dropwise 200.0 L of DiI solution [6.0 L of DiI (10 mg/mL) in 194 L of DMSO] with mixing (1000 rpm) at room temperature. Afterward, the preparation was dialyzed (MWCO: 30K) against deionized water to remove any free DiI and finally was dialyzed overnight in phosphate-buffered saline (1X PBS) to reconstitute the final preparation in PBS.
Characterization. The various polymer-coated nanoceria preparations were charecterized by transmission electron microscopy (TEM) to confirm the size of the nanocrystal core. TEM was performed by mounting a drop of nanoparticles on a holey carboncoated copper 400-mesh grid (2SPI, USA), and images were taken on a FEI TECNAI F30 microscope operating at 300 kV. Surface charge on the nanoparticle was confirmed by potential measurements (Malvern Zetasizer and disposable cells). FT-IR experiments were performed on vacuum-dried samples to verify the surface functionalities on the nanoparticles (Perkin-Elmer Spectrum 100 FT-IR spectrometer). Fluorescence spectroscopy studies were done on DiI-labeled nanoceria using a Nanolog HORIBA JOBIN YVON spectrometer to confirm the DiI dye encapsulation in the nanoparticles.
Cell Culture. All cell lines in this study [lung carcinoma (A549), cardiac myocytes (H9c2), human embryonic kidney (HEK293), and breast carcinoma (MCF-7)] were obtained from ATCC. The cardiomyocytes were grown in Eagle's Minimal Essential medium supplemented with fetal bovine serum (10%), sodium pyruvate, L-glutamine, penicillin, streptomycin, amphotericin B, and nonessential amino acids. HEK293 cells were grown in Eagle's Minimal Essential medium supplemented with fetal bovine serum (10%) and 1% penicillin. The lung cancer cells were grown in Kaighn's modification of Ham's F12 medium (F12K) supplemented with 5% fetal bovine serum, L-glutamine, streptomycin, amphotericin B, and sodium bicarbonate. All cell lines were maintained at 37°C, 5% CO 2 in a humidified incubator. MCF-7 cells were grown in Eagle's Minimal Essential medium supplemented with fetal bovine serum (10%) with 0.01 mg/mL bovine insulin and 1% penicillin.
Cellular Uptake of Polymer-Coated Nanoceria [DNC(0), PNC(؊), and ANC(؉)]. Ten thousand cells (cardiomyocytes, human embryonic kidney cells, lung carcinoma cells, and breast carcinoma cells) were seeded in Petri dishes and incubated with DiI-labeled DNC(0), DiI-labeled PNC(Ϫ), and DiI-labeled ANC(ϩ) (1.0 mM) for 3 h at 37°C, 5% CO 2 in a humidified incubator. Then, the cells were washed with 1X PBS and fixed with 10% formalin in 1X PBS. Afterward, the cells were incubated with DAPI (1 mg/mL, Molecular Probes) for 10 min. The cells were washed and visualized with a confocal microscope (Zeiss LSM 510).
Inhibition of Cellular Uptake of the Polymer-Coated Nanoceria. For these studies, 10000 cells (H9c2 and A549) were treated with the inhibitors sodium azide (10 mM) and 2-deoxyglucose (50 mM) for 30 min. Then, the cells were incubated with DiI-labeled PNC(Ϫ) and DiI-labeled ANC(ϩ) preparations (1.0 mM) for 3 h at 37°C, 5% CO 2 in a humidified incubator. Fixation and subsequent staining with DAPI were performed as described above. Experiments were done at 4°Cwith incubation of the cells with the DiI-labeled PNC(Ϫ) and DiI-labeled ANC(ϩ) preparations (1.0 mM) for 3 h.
Lysosomal Staining. After treatment of the corresponding cell lines with DiI-labeled DNC(0), DiI-labeled PNC(Ϫ), and DiI-labeled ANC(ϩ) for 3 h, cells were washed and incubated for 20 min with Lysotracker (Invitrogen) (35 nM) at 37°C, 5% CO 2 in a humidified incubator. Fixation procedures were performed as stated previously.
Lysosomal Isolation and Oxidase-Activity Determination of Entrapped Nanoceria. Lysosomes were isolated using a previously reported procedure described by Schroter et al. 37 Ten thousand cells (cardiomyocytes, human embryonic kidney cells, lung carcinoma cells, and breast carcinoma cells) were seeded in Petri dishes and incubated with ANC(ϩ), PNC(Ϫ), and DNC(0) (1.0 mM) for 3 h at 37°C, 5% CO 2 in a humidified incubator. Then, the cells were washed with 1X PBS, trypsinized, and centrifuged at 1000 rpm for 8 min. In order to isolate the lysosomes, cells were resuspended in an isotonic sucrose solution (1.0 mL, 0.08 M CaCl 2 , 0.25 M sucrose, 10 mM TrisϪHCl) to lyse the cells into cytosolic and organelles fractions and centrifuged at 25000g for 15 min. Subsequently, the supernatant was carefully removed, and the pellet was resuspended in 1.0 mL of 150 mM KCl (10 mM TrisϪHCl, pH 7.4) followed by centrifugation at 25000g for 15 min to sediment the lysosomes. The pellet containing the lysosomes was resuspended in 200 L of TMB (1.0 mg/mL) and incubated overnight at room temperature. After the incubation period, the absorbance at 652 nm of the lysosome suspension was recorded.
Cell Viability Assays. Cells (cardiomyocytes, human embryonic kidney cells, lung carcinoma cells, and breast carcinoma cells) were seeded in 96-well plates at a density of 3000 cells per well and incubated with ANC(ϩ), PNC(Ϫ), and DNC(0) (1.0 mM) for 3 h. Then, 0.5 mM of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (Sigma) was added, followed by incubation for 24 h. After 24 h, the resulting crystals were dissolved in 40 L of acidified 2-propanol, and the absorbance at 570 nm was recorded using a plate reader (Bio-TEK, Synergy HT Multidetection Microplate reader).
